Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,356 | -54,169 | -42,664 | -30,697 | -16,108 |
| Depreciation Amortization | 145 | 1,382 | 942 | 526 | 74 |
| Accounts payable and accrued liabilities | -121 | -5,174 | -6,094 | -2,511 | -4,870 |
| Other Working Capital | -270 | -8,232 | -8,165 | -5,798 | -4,313 |
| Other Operating Activity | 1,490 | 10,966 | 9,930 | 5,104 | 5,131 |
| Operating Cash Flow | $-12,112 | $-55,227 | $-46,051 | $-33,375 | $-20,086 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,242 | -83,965 | 26,500 | -80,416 | -1,000 |
| PPE Investments | -14 | -1,224 | -1,104 | -1,086 | -46 |
| Purchase Of Investment | N/A | -2,500 | -108,858 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -194 | -251 | -251 | -30 |
| Other Investing Activity | 1 | -194 | -251 | -251 | -30 |
| Investing Cash Flow | $30,229 | $-87,883 | $-83,714 | $-81,753 | $-1,076 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 67 | 181 | 224 | 143 | 33 |
| Financing Cash Flow | $67 | $181 | $224 | $143 | $33 |
| Beginning Cash Position | 46,799 | 189,728 | 189,728 | 189,728 | 189,728 |
| End Cash Position | 64,982 | 46,799 | 60,187 | 74,743 | 168,599 |
| Net Cash Flow | $18,184 | $-142,930 | $-129,541 | $-114,986 | $-21,130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,112 | -55,227 | -46,051 | -33,375 | -20,086 |
| Capital Expenditure | -14 | -1,224 | -1,104 | -1,086 | -46 |
| Free Cash Flow | -12,126 | -56,452 | -47,156 | -34,461 | -20,132 |